Malignant Tumors Stem Cell Therapy Development

Cancer is a formidable adversary that affects millions of lives worldwide. Malignant tumors, characterized by uncontrolled cell growth and the potential to spread to other parts of the body, pose a significant threat to human health. Traditional treatments, such as surgery, chemotherapy, and radiation therapy, have been the primary means of addressing cancer. However, they often come with side effects and may not fully eradicate the disease. In the ever-evolving field of medicine, stem cell therapy has emerged as a promising approach to tackling malignant tumors. CD BioSciences offers stem cell therapy development services for malignant tumors, based on out advanced technology and professional team.

Introduction into Malignant Tumors

Malignant tumors, commonly referred to as cancer, represent a diverse group of diseases that can arise in virtually any part of the body. These tumors exhibit uncontrolled cell growth and may invade surrounding tissues or spread to distant sites. The mainstay of treatment for the disease is surgical resection, fractionated radiotherapy and chemotherapy. However, treatment-related side effects, off-target effects, and drug resistance limit the efficacy of many treatment options. In addition, conventional therapies usually fail to eliminate metastatic cancer cells and are highly likely to recur.

Stem Cell Therapy for Malignant Tumors

Stem cell therapy, which involves all procedures using stem cells, offers a promising option in the fight against cancer. As it enhances the targeting of tumors, it can improve the therapeutic efficacy of other therapies, thus reducing off-target events.

Strategies for the application of stem cell therapy in the treatment of cancer (Chu, et al., 2020)

Applications of Stem Cells in Cancer

• HSC transplantation has been used for the reconstitution of blood-forming cells and leukocytes after heavy chemotherapy or radiotherapy.
• ESCs and iPSCs can be used for the production of effector immune cells that are then CAR constructed for adoptive cell transfer technology. In addition, ESCs and iPSCs can be potential sources for the production of anti-cancer vaccines.
• MSCs/NSCs are effective to deliver genes, NPs, and OVs to tumor niche due to their intrinsic tumor tropism. In addition, exosomes extracted from the culture of drug-priming MSCs/NSCs can be used to target the drugs to tumor sites. Moreover, MSCs are capable of reducing GVHD in HSC transplantation.

Our Services

CD BioSciences offers stem cell therapy development service for GI disorders based on our advanced technology and professional team. Our stem cell therapy development services are offered in GI disorders included but not limited as follows:

As a pioneer in biotechnology, CD BioSciences has grown into one of the largest independent biotechnology companies in the world. CD BioSciences is committed to providing professional and efficient service to our customers around the world. If you are interested in our service, please contact us.